The independent news organization of Duke University
At least three coronavirus variants have been identified in positive Duke-administered tests since the start of the semester. Who are Duke’s variant hunters, and how do they identify different versions of the virus?
Fauci and David Rubenstein, Trinity ‘70, discussed the COVID-19 pandemic and vaccine distribution at an event that was livestreamed on Youtube. Fauci said the pandemic situation could improve by March or April if Americans continue to wear masks, practice social distancing and avoid congregating. But he also acknowledged the presence of new threats.
As Duke students await their doses of the COVID-19 vaccine, they have lingering questions about access and acceptance.
Subscribe to our weekly email about what's trending at Duke
Armed with shiny new technology and a major building expansion, Duke is betting big on quantum computing.
When the pandemic upended health care in 2020, Duke Health employees had to evolve their research, priorities and approach to treating patients. That has included testing for the virus and getting workers vaccinated—and reopening the health system to treat things other than the coronavirus.
Despite the excitement and relief brought by news of highly effective COVID-19 vaccines that will likely soon be approved by U.S. regulators, their large-scale manufacturing and distribution is wrought with issues and complexities.
Lefkowitz’s memoir “A Funny Thing Happened on the Way to Stockholm: The Adrenaline-Fueled Adventures of an Accidental Scientist” is set to be released in February of next year. The story builds up to the 2012 Nobel Prize in Chemistry that he shared with his mentee Brian Kobilka. He also shares his experiences as a trained cardiologist who was diagnosed with a heart disease.
Colleges’ decisions to reopen this fall have raised concerns that outbreaks on campus could lead to COVID-19 spreading in college towns. However, a recent geospatial analysis by researchers at Duke and the University of North Carolina at Chapel Hill found little evidence that student cases of COVID-19 at a sample of North Carolina universities had spilled over into the wider community.
A Bass Connections team is researching how the pandemic might impact sexual behavior and sexual health among college students in the Triangle.
After the retraction of a study on hydroxychloroquine with data provided by a Duke alum's company, a Duke study on the drug has felt ripple effects.
Mark McClellan, founding director of the Duke-Margolis Center for Health Policy, spoke on Wednesday to the House Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce as part of a panel of public health scholars.
A global pandemic has upended many facets of life—including the environment.
Segregation in the 20th century contributed to a still-strained relationship between Durham and the Duke Hospital, two Duke professors told a virtual audience at a Tuesday event.
Students heard about health-care policy, voting and more at a Wednesday event.
Why has the COVID-19 pandemic disproportionately affected Black and brown people in the United States?
As precautionary measures taken to prevent the spread of COVID-19 continue, one question is on all of our minds: When is a safe, effective vaccine going to be developed?
Black women with natural hairstyles are commonly perceived by job recruiters as less professional, according to new research from the Fuqua School of Business.
A team of Duke researchers received $7.6 million in federal funds to develop an RNA-based antibody treatment for the prevention of COVID-19. Manufacturing will begin later this year and a Phase 1 clinical trial is on track to begin in early 2021.
COVID-19 has highlighted systemic issues, experts agreed at a Thursday discussion—ones that can’t be resolved with a vaccine.
Masks are the center of new debate following an article by Duke researchers that many took as a warning to not wear neck gaiters.
